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Background: Skin cancer is the most common type of cancer in humans and the incidence is increasing worldwide. Our
objective was to understanding the needs, experiences and knowledge of individuals with Non Melanoma Skin Cancer
(NMSC) from diagnosis up until one year.
Methods: Patients with NMSC completed questionnaires at diagnosis, treatment, 8 weeks post treatment and 12 months
post diagnosis. Body image, psychological morbidity and Quality of Life (QOL) were assessed at each time point, with the
exception of QOL that was not assessed at diagnosis. Knowledge of NMSC was assessed at baseline and 8 weeks. A
sub-sample of participants was also interviewed to allow a more in-depth exploration of patients’ experiences.
Results: 76 participants completed the initial questionnaire, of which 15 were interviewed. Patients were anxious about a
diagnosis of skin cancer, however they were no more depressed or anxious than the general population. QOL
significantly improved from diagnosis to 8 weeks and from diagnosis to one year. Knowledge of NMSC was poor and did
not improve after treatment. Hairdressers were highlighted as playing an important role in raising awareness and
encouraging individuals to seek medical help. Most participants were aware of the need to check their skin for suspicious
lesions but were not sure what to look for. At one year participants had forgotten their experience and were not overly
concerned about skin cancer.
Conclusion: There is a need to raise awareness of the signs and symptoms of NMSC. Information on skin cancer needs
to be tailored to the individual both at the start of treatment and during the follow up months, ensuring that participants’
needs and expectations are met. Targeting education at individuals in the community who regularly come into contact
with skin should help in early identification of NMSC. This is important since skin cancer caught early is easily treatable
and delay in presentation leads to larger and more complex lesions which impacts in terms of increased morbidity and
increased health care costs.
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Skin cancer is the most common type of cancer in
humans [1], accounting for 20% of all cancers diagnosed
in the UK. Around 97% of skin cancers are epithelial in
origin and are either basal cell carcinomas (BCCs) or
squamous cell carcinomas (SCCs), collectively known as
non-melanoma skin cancer (NMSC). A systematic review* Correspondence: fiona.bath-hextall@nottingham.ac.uk
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distribution, and reproduction in any mediumof the worldwide incidence of Non Melanoma Skin Can-
cer (NMSC) [2] has shown that the incidence of NMSC
varies widely with highest rates in Australia (> 1000/
100,000 person-years for BCC) and lowest rates in parts of
Africa (< 1/100,000 person-years for BCC). The average
incidence rates in England were 76.21/100,000 persons
and 22.65/100,000 persons for BCC and SCC respectively.
The incidence rates in the UK appear to be increasing at a
greater rate when compared to the rest of Europe. NMSC
is most common in older age groups but the incidence of
BCC is increasing in the young [3-6]. There are manyntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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reviewed elsewhere [7-9].
The National Institute for Clinical Excellence (NICE)
guidelines for improving care of people with skin tu-
mours [10] highlighted a lack of research into the needs
and experiences of people with skin cancer and the need
for high quality patient information.
A systematic review looking at qualitative research alone
[11] found only two papers that examined the needs and
experiences of people with skin cancer (melanoma and/or
non-melanoma skin cancer). The studies identified by the
review focused mainly on melanoma skin cancer and did
not investigate patients’ perceptions of their information,
support, and decision making needs over the course of
their illness, or the extent to which these had been met. A
study in 40 patients exploring patients’ understanding of
pigmented skin lesions and skin cancer concluded that
changing moles were often perceived as trivial and not sig-
nifying possible skin cancer [12]. A recently published
study looked at 982 consecutive American patients pre-
senting for Mohs micrographic surgery for NMSC and
found that 71% of people delayed going to their doctor
with NMSC because they were in denial about the severity
of their condition [13]. It is known that early diagnosis
can dramatically improve prognosis and the patient ex-
perience since early lesions are treated more simply com-
pared with larger or neglected lesions [13]. It has been
shown that patients with melanoma, BCC and SCC experi-
ence similar levels of anxiety and depression after diagno-
sis and treatment [14], and surgery for skin cancer has
been shown to impact on their appearance [15]. Health
professionals working with skin cancer patients need to
understand the psychosocial concerns of this patient group
in order to design services appropriately and to provide
patients with the support they need and information that
they can easily understand. The patient experience is an
important component in the evidence based cycle. Re-
search in this area has predominantly focused on malig-
nant melanoma. This study combines both quantitative
and qualitative methods to follow skin cancer patients on
their journey from diagnosis to one year post diagnosis.
Methods
A mixed method study, using postal questionnaires and
semi structured interviews. Our objective was to under-
stand the needs, experiences and knowledge of individ-
uals with Non Melanoma Skin Cancer (NMSC) from
diagnosis up until one year.
Consecutive patients, referred from primary care, at-
tending a skin cancer clinic in a large teaching hospital
in the East Midlands over an 8 month period in 2008/9
with a new clinical diagnosis of NMSC, were invited to take
part in the study. No recurrent cases were included how-
ever patients with previous skin cancer were not excluded.Ethical approval was obtained from the Nottingham Re-
search Ethics Committee 1 (08/H0403/83) and signed con-
sent was obtained from all participants.
Questionnaires (Additional files 1 and 2) were sent to
patients at four time points: baseline (just after diagno-
sis, usually the next day), treatment (same day or next
day), 8 weeks post-treatment and 12 months from baseline.
Body image and psychological morbidity were assessed at
each time point using the Derriford Appearance Scale 24
(DAS24) [16] and the Hospital Anxiety and Depression
Scale (HADS) [17]. Knowledge of NMSC was assessed at
baseline and 8 weeks post-treatment. This instrument was
adapted from the melanoma knowledge questionnaire [18]
in consultation with dermatologists and piloted prior to
use. Demographics and sun exposure data were collected
at baseline and participants’ concerns about how NMSC af-
fected their quality of life were assessed after treatment,
8 weeks post-treatment and at 12 months from baseline
using the Skin Cancer Index (SCI) [19]. See study flow
chart, Figure 1. SCI was not assessed at baseline as the
questions were deemed inappropriate for patients who had
just received a diagnosis of NMSC.
We invited all participants to take part in an interview.
Purposive sampling ensured we captured a proportion of
younger people (< 60 yrs). Interviews were designed to elicit
in-depth views, perceptions and descriptions of the experi-
ence of being treated for NMSC, recovery from treatment
and feelings 12 months after diagnosis. A flexible interview
guide (Additional file 3) was used to ensure consistency
across the interviews while allowing interviewees to express
their ideas, understanding and concerns freely.
Anxiety and Depression were measured using the Hos-
pital Anxiety and Depression Scale (HADS), a 14-item
self-rating scale, with questions pertaining to the past
week, in medical outpatients, primary care and commu-
nity settings, which have been validated for cancer pa-
tients. The HADS was answered by the participant on a
four-point (0–3) response category with a possible score
of 0 to 21 for anxiety (7 items) and for depression (7
items). For each construct, a score below 8 was classified
as ‘normal’, 8–10 as ‘borderline’ and above 10 as ‘case-
ness’ (probable presence of disorder).
The Derriford Appearance Scale (DAS24) is a 24-item
scale designed to measure distress and dysfunction in rela-
tion to problems of appearance. Some of the items request
a response about the intensity of emotional response, using
response categories of ‘extremely’ to ‘not at all’ (e.g. ‘How
distressed do you get when you see yourself in the mirror/
window?’). Other items ask about the frequency of particu-
lar behaviours indicative of a self-conscious response (e.g.
‘I avoid going out of the house’), using an ‘almost always’ to
‘never/almost never’ set of response categories. Where ap-
propriate, a response of ‘not applicable’ is allowed. There is
no threshold score or cut-off point to indicate ‘caseness’.
New clinical diagnosis of Non 
Melanoma Skin Cancer (NMSC)
N=135
Agreed to take part N=77
Baseline
Given questionnaire 1 *
Treatment 
Given questionnaire 2 *
8 weeks post treatment
Given questionnaire 3 *
12 months from baseline
Given questionnaire 4 *
8 weeks
12 months
*interview time points for those participants 
who agreed to be interviewed 
Variable time 
Figure 1 Study flow diagram.
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distress/dysfunction).
Knowledge of NMSC was ascertained using three free-
response questions to assess knowledge about how to re-
duce risk from NMSC (one mark for each of avoiding
sunburn, not using sun beds, checking skin frequently),
what type of people are at risk of NMSC (one mark for
each of fair skin, sunbather, work outdoors, use of sun
beds, previous skin cancer/family history of skin cancer,
older age), and early skin signs of NMSC (one mark for
stating any of the following: lump/pearly lump/change in
lump/sore/unusual area/new area/recently grown plus one
mark for mentioning a surface change that is non-healing :
crusting, scabbing, bleeding plus half a mark for using the
word raised). The maximum possible score is 11.5.
The Skin Cancer Index (SCI) is a 15 item, validated,
disease-specific QOL instrument with 3 distinct subscales,
Emotion, Social, and Appearance. Higher scores reflect bet-
ter quality of life [20]. Summary statistics were computed
for each SCI question, the three SCI subscale totals, and
the overall SCI total. The subscales were transformed so
that each subscale, and the total, was between 0 and 100.
All quantitative analyses was performed using SPSS
version 16.0. Summary statistics were computed for the
HADS anxiety and depression, DAS24, Knowledge ofNMSC, and total SCI. 95% confidence intervals for the
means of each outcome were calculated at various time
points and for the change over time windows. We used
paired t test for examining the HADS, DAS24 and also the
SCI index. We calculated the mean change in HADS anx-
iety and depression and DAS24 across three different time
windows: baseline – 12 months post baseline, treatment –
eight weeks post treatment, and treatment – 12 months
post baseline. We also calculated the mean change in SCI
across 2 different time windows: treatment - 8 weeks post
treatment and treatment - 12 months post baseline.
Interviews were transcribed and analysed using thematic
content analysis [21]. The qualitative data analysis package
NVivo8 was used to deductively and inductively derive
codes and check that these harmonized with the context of
the interview statement. Codes were grouped into clusters
and categorised into major themes. Members of the team
collectively analysed and discussed the emerging themes.
Results
One hundred and thirty five patients with an initial clin-
ical diagnosis of NMSC were referred to the researcher
by the clinician of whom 77 (57%) agreed to take part in
the study and returned a consent form. The clinical
diagnosis was confirmed in all but one person who was
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(range 35–89), 40 (53%) were male and a quarter re-
ported having had a previous skin cancer. BCC was the
most common (80%), the majority of which were on the
head or neck, Table 1. Twenty nine percent of the par-
ticipants had outdoor occupations and 20% of partici-
pants had lived abroad. Over half of the participants had
sunburn (causing pain/discomfort/peeling) as a child (32%
had 1–2 episodes and 25% had > = 3 episodes). Seventeen
percent had sunburn in the last two years (38% were
under 60 years of age and 12% were over 60 years of age).
Seventy seven percent of participants spent between 1–
4 weeks on holiday and 11% spent between 5–12 weeks
on holiday. Seven percent of participants aged > 60 yrs fre-
quently sunbathed compared to 14% in the 40–60 year
olds and 33% of those < 40 yrs. Of the participants who
sunbathed, 78% used sunscreen although most partici-
pants were unsure as to the SPF.
The time from first clinic visit to treatment varied from
0 to 159 days (median 41 days, IQR 23.5 - 57.5 days).
Sixty-eight participants were treated by excision, one was
treated by excision followed by radiotherapy and 8 were
treated by Mohs micrographic surgery. The mean time
from diagnosis to treatment for Mohs micrographic sur-
gery was 101 days (SD 33.33, range 47–159 days). The
mean time from diagnosis to treatment for excision was
37.18 days. Two patients received diagnosis and treatment
on the same day and resultant histology confirmed their
clinical diagnosis. Participants’ demographics and disease
characteristics are shown in Table 1.
The mean age of the interviewees was 66 (range 39–
88). Four were aged ≤ 60 years. Thirteen were clinically
diagnosed with BCC and 2 with SCC. Six participants
(40%) were male and 3 (20%) reported having had a pre-
vious skin cancer. The site of skin cancer was located on
the head for all but one interviewee whose lesion was on
the torso. Ten of the participants sunbathed regularly,
five had used sun beds, four had been sunburnt in the
past 2 years, five spent more than 50% of their holidays
abroad, three had lived abroad in hot countries and two
remembered getting sunburnt as a child.
Quantitative results
Baseline, treatment, 8 weeks post-treatment and 12 months
post-baseline questionnaires were returned by 76, 67, 67,
and 66 participants respectively. A number of participants
did not return the questionnaires at various time points
but no reasons were given. A number of participants with-
drew (one due to broken ankle, three due to a broken
limb, one lesion was not a NMSC, one gave no reason and
one died (not related to NMSC) 8 weeks post treatment.
Baseline scores for HADS anxiety and depression were
classified as normal for 84% (anxiety) and 93% (depres-
sion) of the participants respectively. The DAS24 scoreswere consistent with those reported by a general (non-
patient) population (Table 1). Knowledge of NMSC was
low (range 0–7.5) with a mean total score of 3.28/11.5
(SD 1.61). There were no significant gender differences
with respect to anxiety (p = 0.087), depression (p = 0.274),
DAS24 (p = 0.213), or knowledge (p = 0.371). Knowledge
was no better in participants who had previously had a
skin cancer. A significant positive correlation was found
between age and depression with older people having
higher depression scores (Rs = 0.374, p = 0.001). A signifi-
cant positive correlation was seen between the HADS
Anxiety score and DAS24 score (Rs = 0.454, p < 0.001),
with those with higher DAS24 scores (poorer body image)
having a higher anxiety score.
Quality of life significantly improved from treatment
to 8 weeks post treatment (p = 0.034) and from treat-
ment to 12 months post baseline (p = 0.001) (Table 2).
There was no significant change in body image from
baseline to 12 months post baseline or from treatment
to 8 weeks post treatment (Table 2). There was no sig-
nificant change in knowledge of NMSC from baseline to
8 weeks post treatment (Table 3).
Although mean anxiety and depression scores were in
the normal range (≤ 8.0) at each time point (Table 2), we
found that patients became even less anxious (p = 0.003)
and depressed (p = 0.003) 12 months post diagnosis
(Table 2).
Qualitative results
Forty one participants (53%) consented to be interviewed.
Of these 15 were interviewed. These 15 were selected to
give us a broad a range of views and experiences as pos-
sible covering gender, age (above and below 60). The in-
terviews were conducted over the telephone with the
exception of one interviewee who was interviewed face to
face. The interviews were audio-taped and fully tran-
scribed. There were no significant differences in demo-
graphics between the participants interviewed and those
comprising the whole study.
At baseline (just after diagnosis) four major themes
emerged from analysis of the 15 interviewees : Chance
and cue to action; Rationalisation for delay in seeking
medical help; Reaction to clinical diagnosis and I’m quite
aware now. The themes and their variations are described
below and highlighted by comments from interviewees.
Chance and cue to action
Participants were asked what prompted them to go to
their doctor. Reasons included the inability of their skin
condition to heal completely and the persistent cycle of
bleeding, scab formation and re-emergence. Others recalled
visiting their general practitioner for some other reason and
just mentioning in passing a skin condition that they were
not particularly concerned about. A number of participants
Table 1 Demographic characteristic of participants
Characteristics No (%) of participants
Age, yrs
30-49 5 (7)
50-59 11 (15)
60-69 15 (20)
70-79 28 (37)
80-89 17 (22)
Sex
Male 40 (53)
Female 36 (47)
Marital status
Single 5 (7)
Married 47 (62)
Living with partner 5 (7)
Widowed 14 (8)
Divorced 5 (7)
Previous skin cancer
No 56 (74)
Yes 19 (25)
Missing 1 (1)
Histology
BCC 61 (80)
SCC 14 (18)
Missing 1 (1)
Site
Head/neck 60 (79)
Rest of body 15 (20)
Missing 1 (1)
Diameter (mm)
1-4 12 (16)
5-9 36 (47)
> = 10 19 (25)
Missing 9 (12)
HADS Median (IQR) 6.0 (1–11)
Anxiety
0-7 63 (84)
8-10 8 (11)
> = 11 4 (5)
Median (IQR) 3.0 (1–6)
Depression
0-7 70 (93)
8-10 2 (3)
Table 1 Demographic characteristic of participants
(Continued)
> = 11 3 (4)
Median (IQR) 2.0 (0–5)
DAS-24 (N = 69) Mean (SD) 23.7 (8.8)
SD standard deviation.
BCC Basal Cell Carcinoma.
SCC Squamous Cell Carcinoma.
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to the skin lesion and suggested they went to see their gen-
eral practitioner. Other individuals who encouraged partici-
pants to seek advice included a community skin cancer
specialist (7%), a dentist (7%) and a friend (7%). A number
of participants (some of whom had a previous experience
of skin cancer), visited their general practitioner without
prompting (66%).
“My hairdresser said to me, a few weeks ago, “The next
time you go to the doctor’s mention the mark on your
temple,” he said, “because I don’t like the looks of it”…
and it wasn’t until I went to the doctor’s about three
weeks ago when I thought, "Oh”, I said, “can you just
have a look at this mark on my temple, the hairdresser
told me to mention it to you.” And he looked at it, and
then he got a magnifying glass and he said, “I don’t
think it's anything to worry about but I’ll refer you to
a dermatologist…”
F, 74, BCC
Rationalisation for delay in seeking medical help
Most participants found it difficult to remember exactly
when they first noticed the lesion. A lack of awareness that
it could be skin cancer was the main reason for delay. The
majority were aware of the skin lesion and that it some-
times caused physical discomfort such as irritation or
bleeding and failed to heal. The lesion was often attributed
to being a minor skin condition, a symptom of old age
that might heal on its own and nothing to worry about.
“I’d got a spot that was reoccurring and didn’t know
whether it was just old age or whether it was
something that was untoward… I didn’t really see it as
a priority. I wish I’d have gone earlier but at the time
didn’t think it was anything.”
F, 39, BCC
“It’s over five years because I'd had had this tiny red
patch…I mean I'm saying five years, it could have
been ten years… I just assumed it was definitely a
Table 2 Changes in quantitative outcomes over time
Scale Comparison Mean (95% CI) P value
DAS-24 Baseline to 12 months post diagnosis (N = 59) 0.289
23.9 (21.5,26.3) to 23.0 (20.9,25.2)
Treatment to 8 week post treatment (N = 61) 0.306
23.0 (20.8,25.3) to 22.2 (20.2,24.2)
HADS
Anxiety Baseline to 12 months post diagnosis (N = 62) 0.003
3.6 (2.7,4.4) to 2.5 (1.8,3.3)
Treatment to 8 week post treatment (N = 59) 0.026
3.1 (2.2,3.9) to 2.5 (1.7,3.2)
Depression Baseline to 12 months post diagnosis (N = 59) 0.003
2.9 (2.0,3.7) to 1.9 (1.2,2.6)
Treatment to 8 week post treatment (N = 59) 0.848
2.2 (1.5,2.9) to 2.2 (1.4,2.9)
SCI Treatment to 8 weeks post treatment (N = 63) 0.034
78.21 (73.8, 82.6) to 82.3 (78.6, 85.9)
Treatment to 12 months post diagnosis (N = 57) 0.001
78.4 (73.8, 83.0) to 85.5 (82.0, 89.0)
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it could be skin cancer.”
F, 67, BCC
Reaction to clinical diagnosis
The mention of the word ‘cancer’ caused alarm and con-
cern for most participants. Concern was mainly about how
long they had had the cancer and if it could have spread
and if they had other undetected skin cancers. Appearance
and potential disfigurement following treatment was an-
other concern. All patients felt they had a good rapport
with the dermatologist, however some participants felt
their information needs had not been met and thought
they should have received more information especially
when some patients compared the information given to
them with that given to patients with other types of cancer.
“You know, to the person who has actually got it it’s
not relatively minor… it’s that big C word again, andTable 3 Knowledge of Non Melanoma Skin Cancer (NMSC)
Baseline 8 weeks after treatme
Knowledge Category n, Mean (SD) n, Mean (SD)
Reduce Risk 76, 1.00 (0.40) 67, 1.02 (0.41)
Risk Type 76, 1.39 (0.97) 67, 1.30 (0.80)
Signs of NMSC 76, 0.89 (0.78) 67, 0.72 (0.70)
Total Knowledge 76, 3.28 (1.61) 67, 3.03 (1.28)
*Difference in scores based on 67 participants with baseline and 8 weeks after treawhile it’s there it can spread. But that’s a personal
feeling of mine and I don't know how many people are
diagnosed with this type of thing yearly but I bet most
people feel the same.”
M, 55, SCC
‘I'm quite aware now’
Several participants felt that having experienced a
NMSC they would generally know what to look for in
future and would have the confidence to act more quickly
in presenting to a general practitioner. Others were aware
of the need to check the skin but were not sure what to
look for. Some participants remained unaware that they
needed to check their skin but some participants changed
their behaviour.
“Well, I mean, yeah, if anything, I got a scab and I
were picking it well I’d be straight to the doctors”
F, 69, BCC
“I wear cream all the time. I wear a hat all the time
now as well. I don’t sit in the sun, I used to years ago, I
used to sit in the sun a lot, but I don’t do that anymore.”
F, 70, BCC
Immediately post treatment the themes to emerge were:
Treatment satisfaction; Appearance and information needs;
Recurrence and new lesions; Increased awareness.Treatment satisfaction
All patients were satisfied with their care. For most,
treatment satisfaction was associated with the knowledge
that their skin cancer had been completely removed.
“The good thing is the bad stuff ’s gone and I’m not
that vain, if you know what I mean.”
M, 45, BCCnt Mean difference (95% CI)* P value for difference
0.03 (−0.07-0.13) 0.57
−0.10 (−0.36-0.15) 0.42
−0.19 (−0.41-0.04) 0.10
−0.32 (−0.69-0.05) 0.09
tment scores.
Bath-Hextall et al. BMC Dermatology 2013, 13:13 Page 7 of 10
http://www.biomedcentral.com/1471-5945/13/13Appearance and information needs
Potential disfigurement and scarring was a concern for
many patients. Participants were concerned that they had
no information about what was happening after the
treatments.
“I was a little anxious because I didn’t quite know
what I was going to look like when I was finished.”
F, 62, BCC
“Maybe a little bit more information about what the scar
would feel like and look like and, you know, I’m not sure
whether this lumpiness and the hardness of the scar is
going to soften and go away or whether it’s permanent”.
F,67, BCC
Recurrence and new lesions
Patients were concerned that although the lesion had
been removed, it might come back and they worried
about further lumps and bumps.
“Well, it’s just that, you know, I just hope that it’s all
gone and that it’s not going to flare up again. I mean,
I'm touching wood, I don’t think it will do because I
don’t think it was that sort of thing, but there's bound
to be doubts, small doubts, you know, even though
people do try and reassure you. But hopefully
everything will be okay.”
F, 74, BCC
Increased awareness
Patients were more aware of skin cancer and were taking
steps to avoid getting another lesion. They were checking
for new lesions, although some were not sure what they
were looking for. Participants also said they were spread-
ing the word to others about the need to check their skin.
“… it has raised awareness significantly in our family
now, yeah....I've been into town today and bought a
moisturiser with SPF25 or something or other, so yeah.
So I'll wear that constantly now rather than general
moisturisers.”
F, 39, BCC
“I am [checking], yes, but I’m not too sure what to look
for.... Now if I see anything that’s not, I’ll be, instead of
waiting I shall be straight to the doctor’s and see what
it is.”
M, 45, BCC8 weeks post treatment the main themes to emerge
were: Information needs about checking skin; Spreading
the word.
Patients understood the need to continue to check for
further skin lesions although most were not sure what
they were looking for. Many participants continued to
spread the word about skin cancer advising others to
seek medical advice regarding suspicious lesions.
Information needs about checking skin
“Well I mean in my experience the problem has not
known what to look for. I mean if all these things were
identical in appearance, then I would feel a lot easier.
But by and large they’ve taken different forms, and it
is a question of knowing what to look for ....”
M, 78, BCC
Speading the word
“One or two people I have spoken to and I’ve said, I
did say look out for dubious looking spots and things
that won’t go away with ointments and things.”
F, 79, BCC
12 months post baseline the main themes to emerge at
one year post diagnosis were Satisfaction and Not sure
what to look for?
One year on, most people were satisfied with the treat-
ment and care they had received. They were happy that
their NMSC had been completely removed and that any
scaring had healed. Some participants continue to check
their skin but were still not sure what to look for. Inter-
estingly, when they spoke about skin cancer they spoke
about moles despite having had a non melanoma skin
cancer.
Satisfaction
“I’m fine, absolutely fine, I don’t really think about it
at all. I had this spot and they took it off and its fine.
It doesn’t worry me at all.”
F, 64, BCC
Not sure what to look for?
“I wasn’t really given any advice on checking it at
all. You know, I was just told that it was sun
damage on my face and on my nose but I wasn’t
given any advice on how to check it. I mean I know,
I've read up a lot about it, so I know that I check
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get my husband to check, and I always check his
regularly as well.”
F, 70, BCC
Discussion
Although not a life threatening disease, a diagnosis of
NMSC caused concern for many participants, and whilst
this was not evident from the total quantitative data this
was evident from those we interviewed. At diagnosis our
participants were neither clinically anxious nor depressed;
however, levels of anxiety were higher than levels of de-
pression and 16% of our participants experienced signifi-
cant levels of psychological distress. These results are
similar to another study that found 19% of NMSC patient
experienced significant levels of psychological distress [22].
Participants who were most anxious had a poorer body
image although body image scores were not high and were
representative of the general population who are not con-
cerned about their appearance [16]. A review of psycho-
logical distress in patients with melanoma also found
participants more anxious than depressed [23]. Our study
participants were anxious at diagnosis when they heard
the word cancer. They were concerned about how long
they had had the cancer, whether it had spread and pos-
sible disfigurement. Eight weeks after treatment partici-
pants were significantly less anxious and when interviewed,
said that the concerns they had at treatment no longer
existed. By 12 months, participants had forgotten any con-
cerns that they may have had. Anxiety, depression and
quality of life all significantly improved post diagnosis.
Knowledge of NMSC was very poor, even among those
who had skin cancer previously.
A telephone survey in recently treated Squamous Cell
Carcinoma patients in Italy also found skin cancer know-
ledge to be low [24]. We found no significant difference in
knowledge from diagnosis to 8 weeks post treatment. Par-
ticipants told us that information given at diagnosis was
not really considered as they were so shocked at hearing
the word ‘cancer’ that everything went out of their head
and they couldn’t think of anything else. Lack of knowledge
of NMSC most likely contributed to the delay in presenta-
tion for many of the participants with some not consulting
a doctor for up to 2–5 years. Our study found lack of
awareness to be one of the main reasons for delay. Despite
participants being aware of their skin lesion for many years,
most thought it was a sign of ageing or something that
would go away despite in many cases the lesion repeatedly
bleeding and failing to heal and despite self-treating with
various creams. A recent study [13] in patients presenting
for Mohs micrographic surgery for NMSC found similar
reasons for delay in presentation, however they did not look
at what prompted people to eventually seek advice. Wefound many participants only consulted a doctor after
others such as hairdressers, dentist, or friends had encour-
aged them to do so. Knowledge is a necessary prerequisite
for anyone to be able to interpret a symptom as a signal of
cancer or to judge it as serious and requiring medical atten-
tion [25].
Hairdressers were highlighted in this study as playing
an important role in raising awareness and encouraging
their clients to seek medical help. A recent study that
surveyed hair professionals provides evidence that hair
professionals would be receptive to skin cancer educa-
tion especially as they are already looking for suspicious
lesions on customers’ scalp, neck, and face and are acting
as lay skin cancer educators [26]. The regular contact hair-
dressers have with their clients ensures familiarity with
their clients’ skin and therefore they are in a good position
to see unusual changes on the head and neck. These find-
ings add to the evidence that educating people about skin
cancer is crucial in identifying and thus appropriately
treating the disease [27]. Two recently published com-
mentaries have considered the possibility of utilizing hair-
dressers for early detection of head and neck melanoma
[28] and have suggested that hair salon operators should
perform opportunistic surveillance of their clients to rec-
ognise suspicious lesions and then advise that they see
their doctor [29].
The main concern of our patients at 12 months after
diagnosis was that they were still not sure if they would
recognise skin changes that might be skin cancer. It is
interesting to note that whilst most of our participants
at 12 months were still aware of the need to be cautious
in the sun, they talked about checking skin for moles
with no mention of Non Melanoma Skin Cancer. Know-
ledge of the risk factors for skin cancer has been found
to increase skin surveillance, which in turn is associated
with thinner melanoma tumours [30].
Despite there being no change in body image over the
course of the study, participants continued to be con-
cerned about their appearance at 8 weeks post treatment.
Quality of life of our participants improved significantly
over time and like those in the SCI validation study by
Rhee et al., [19] were skewed to the upper range. Our
8 week post-treatment mean total SCI of 82.2 is 6% higher
than the 16 week post-surgery score (77.3) in Rhee’s study
of 183 patients with a biopsy proven NMSC of the face or
neck referred to a dermatological Mohs micrographic sur-
gery clinic. Our group was older, had a higher percentage
of men and relatively few patients underwent Mohs micro-
graphic surgery, factors which may account for our rela-
tively high quality of life scores.
Strengths and limitations
A strength of our study was that we were able to follow
participants over time from diagnosis through treatment
Bath-Hextall et al. BMC Dermatology 2013, 13:13 Page 9 of 10
http://www.biomedcentral.com/1471-5945/13/13and a year following diagnosis. A limitation of this study
may be that we recruited from only one out-patient clinic;
patients are, however, referred to this large teaching hos-
pital from a very wide area and are representative of the
general population. Another limitation may be that we
adapted the knowledge questionnaire from a melanoma
knowledge questionnaire, although upmost care was taken
in doing this in close consultation with clinicians.
Conclusions
Information on skin cancer needs to be tailored to the
individual both at the start of treatment and during the
follow up months, ensuring that the participants’ needs
and expectations are met. There is a real need to raise
awareness of the signs and symptoms of NMSC especially
in elderly populations. Knowledge about recognising the
signs of skin cancer is particularly important since 44% of
patients will develop additional lesions within 3 years [31].
Targeting education at individuals in the community who
regularly come into contact with skin should help in early
identification of NMSC. This is important since skin can-
cers caught early are easily treatable and delay in presenta-
tion leads to larger and more complex lesions which in
turn may increase patient morbidity and increased health
care costs.
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